← FDA Drug Approvals (Drugs@FDA)

TERIFLUNOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2023-03-13

Drug application

FDA Application #

ANDA209639

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERIFLUNOMIDE

Generic name

TERIFLUNOMIDE

Active ingredients

TERIFLUNOMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

Biocon Pharma Inc.

First approval

2023-03-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown